| Product Code: ETC7652355 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Gastric Cancer Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Gastric Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Gastric Cancer Market - Industry Life Cycle |
3.4 Israel Gastric Cancer Market - Porter's Five Forces |
3.5 Israel Gastric Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Gastric Cancer Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.7 Israel Gastric Cancer Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Israel Gastric Cancer Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 Israel Gastric Cancer Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Israel Gastric Cancer Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Israel Gastric Cancer Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Gastric Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastric cancer in Israel |
4.2.2 Technological advancements in diagnostic tools and treatment options |
4.2.3 Growing awareness about early detection and screening programs |
4.3 Market Restraints |
4.3.1 High cost of cancer treatment and care |
4.3.2 Limited access to advanced healthcare facilities in certain regions of Israel |
4.3.3 Regulatory challenges and strict approval processes for new therapies |
5 Israel Gastric Cancer Market Trends |
6 Israel Gastric Cancer Market, By Types |
6.1 Israel Gastric Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Gastric Cancer Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Gastric Cancer Market Revenues & Volume, By Adenocarcinoma, 2021- 2031F |
6.1.4 Israel Gastric Cancer Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.1.5 Israel Gastric Cancer Market Revenues & Volume, By Gastrointestinal Stromal Tumor, 2021- 2031F |
6.1.6 Israel Gastric Cancer Market Revenues & Volume, By Carcinoid Tumor, 2021- 2031F |
6.1.7 Israel Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Gastric Cancer Market, By Stages |
6.2.1 Overview and Analysis |
6.2.2 Israel Gastric Cancer Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.3 Israel Gastric Cancer Market Revenues & Volume, By Stage II, 2021- 2031F |
6.2.4 Israel Gastric Cancer Market Revenues & Volume, By Stage III, 2021- 2031F |
6.2.5 Israel Gastric Cancer Market Revenues & Volume, By Stage IV, 2021- 2031F |
6.2.6 Israel Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Gastric Cancer Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Israel Gastric Cancer Market Revenues & Volume, By Endoscopy, 2021- 2031F |
6.3.3 Israel Gastric Cancer Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.3.4 Israel Gastric Cancer Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.3.5 Israel Gastric Cancer Market Revenues & Volume, By Exploratory Surgery, 2021- 2031F |
6.3.6 Israel Gastric Cancer Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Israel Gastric Cancer Market, By Treatment |
6.4.1 Overview and Analysis |
6.4.2 Israel Gastric Cancer Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4.3 Israel Gastric Cancer Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.4.4 Israel Gastric Cancer Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.5 Israel Gastric Cancer Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.4.6 Israel Gastric Cancer Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.4.7 Israel Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Gastric Cancer Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Israel Gastric Cancer Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Israel Gastric Cancer Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 Israel Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Gastric Cancer Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Israel Gastric Cancer Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Israel Gastric Cancer Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 Israel Gastric Cancer Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.6.5 Israel Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Israel Gastric Cancer Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Israel Gastric Cancer Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Israel Gastric Cancer Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7.4 Israel Gastric Cancer Market Revenues & Volume, By , 2021- 2031F |
7 Israel Gastric Cancer Market Import-Export Trade Statistics |
7.1 Israel Gastric Cancer Market Export to Major Countries |
7.2 Israel Gastric Cancer Market Imports from Major Countries |
8 Israel Gastric Cancer Market Key Performance Indicators |
8.1 Survival rate of gastric cancer patients in Israel |
8.2 Adoption rate of innovative treatment modalities |
8.3 Participation rate in gastric cancer screening programs |
8.4 Rate of early-stage diagnosis of gastric cancer |
8.5 Patient satisfaction with gastric cancer care services provided |
9 Israel Gastric Cancer Market - Opportunity Assessment |
9.1 Israel Gastric Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Gastric Cancer Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.3 Israel Gastric Cancer Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Israel Gastric Cancer Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.5 Israel Gastric Cancer Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Israel Gastric Cancer Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Israel Gastric Cancer Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Gastric Cancer Market - Competitive Landscape |
10.1 Israel Gastric Cancer Market Revenue Share, By Companies, 2024 |
10.2 Israel Gastric Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here